Significant Risks and Uncertainties Including Business and Credit Concentrations (Tables)

9 Months Ended

Sep. 30, 2023

Risks and Uncertainties [Abstract]

Summary of Concentration Risk

The concentration of net revenue on a percentage basis for major payors for the three and nine months ended September 30, 2023 and 2022 are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Percentage of Patient Services Net Revenue:
Payor A	11	%	12	%	11	%	14	%
Payor B	14	%	15	%	14	%	16	%

The concentration of gross receivables on a percentage basis for major payors at September 30, 2023 and December 31, 2022 are as follows:

	September 30, 2023		December 31, 2022
Percentage of Gross Receivables of Patient Revenue:
Payor B	10	%	13	%
Payor C	8	%	10	%

The concentration of cost of sales on a percentage basis for major vendors for the three and nine months ended September 30, 2023 and 2022 are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Percentage of Cost of Sales:
Vendor A	100	%	97	%	100	%	69%
Vendor B	N/A		N/A		N/A		29%

The concentration of gross payables on a percentage basis for major payors at September 30, 2023 and December 31, 2022 are as follows:

	September 30, 2023		December 31, 2022
Percentage of Gross Payables:
Vendor A	48	%	66	%
Vendor B	12	%	N/A